13D Filing: Park West Asset Management and PLX Pharma Inc. (PLXP)

*Beneficial ownership percentage is based upon 8,721,691 shares of Common Stock issued and outstanding as of November
3, 2017, based on information reported by the Issuer in its quarterly report on Form 10-Q, filed with the Securities and Exchange
Commission on November 9, 2017. As of the Event Date, PWIMF held 953,465 shares of Common Stock and, subject to the limitation
described below, warrants to purchase up to 902,528 shares of Common Stock. The warrants are not exercisable until December 15,
2017, expire on June 14, 2027, and contain a provision prohibiting exercise to the extent that the holder, together with its affiliates,
would beneficially own in excess of 9.99% of the number of shares of Common Stock outstanding immediately after giving effect to
such exercise (subject to decrease upon prior written notice to the Issuer).  For purposes of Reg. Section 240.13d-3,
PWIMF may be deemed to beneficially own 953,465 shares of Common Stock, and no shares of Common Stock underlying the warrants,
for an aggregate beneficial ownership percentage of approximately 10.9% of the shares of Common Stock deemed issued and outstanding
as of the Event Date.